A 58-year-old man is evaluated in the hospital for worsening abdominal distension and diffuse abdominal discomfort over the past 48 hours. He has a history of alcohol-associated cirrhosis. His temperature is (), blood pressure is , and pulse is . Physical examination shows a protuberant abdomen with shifting dullness and mild, diffuse tenderness to palpation without rebound or guarding. Neurologic examination shows a fully oriented patient with no asterixis.
Laboratory studies show the following:
| Test | Result |
|---|---|
| Serum creatinine | |
| Blood urea nitrogen | |
| Total bilirubin |
Diagnostic paracentesis yields ascitic fluid with a total leukocyte count of and neutrophils. Intravenous cefotaxime is initiated. Which of the following is the most appropriate additional intervention for this patient?
- Administration of intravenous albuminAnswer
- BAddition of intravenous metronidazole
- CLarge-volume therapeutic paracentesis
- DPlacement of a transjugular intrahepatic portosystemic shunt
- ETransfusion of fresh frozen plasma
Answer
Administration of intravenous albumin
The correct intervention is the administration of intravenous albumin. This patient has spontaneous bacterial peritonitis (SBP), diagnosed by an ascitic fluid absolute neutrophil count (ANC) greater than (in this case, ). SBP can precipitate severe splanchnic arterial vasodilation, leading to decreased effective arterial blood volume, activation of the renin-angiotensin-aldosterone system, and subsequent severe renal vasoconstriction, a cascade known as hepatorenal syndrome (HRS). The administration of intravenous albumin expands the intravascular volume, binds vasodilatory molecules, and significantly reduces the incidence of HRS, thereby improving survival. It is specifically indicated for patients with SBP who have a serum creatinine , BUN , or total bilirubin . This patient meets all three of these criteria.
Step-by-Step Solution
Key Concept
Management of spontaneous bacterial peritonitis and prevention of hepatorenal syndrome using intravenous albumin.